comparemela.com

Latest Breaking News On - Aquapharm chemicals private limited - Page 1 : comparemela.com

Share Market Highlights 1 February 2024: Indian Indices turn choppy post Budget presentation; media, metal stocks drag; banking, auto stocks shine

Share Market Highlights 1 February 2024: Indian Indices turn choppy post Budget presentation; media, metal stocks drag; banking, auto stocks shine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

PCBL shares gain 3% on buying Aquapharm Chemicals for Rs 3,800 crore

The company has executed a share purchase agreement with ACPL, Mr. Vimal V. Mangwani, Mr. Dharmesh Mangwani, Mr. Nitin Raojibhai Desai and other shareholders of ACPL.

Stock Market Live Updates 29 November 2023: Sensex and Nifty surge on global optimism; Tech Mahindra gains over 2%

Stock Market Live Updates 29 November 2023: Sensex and Nifty surge on global optimism; Tech Mahindra gains over 2%
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Phillips Carbon Black | PCBL in Rs 3,800 crore deal to buy Pune-based speciality chemicals company Aquapharm

Aquapharm, which had a consolidated turnover of Rs 2,008.8 crore and EBIDTA of Rs 417 crore in 2022-23, is a private company engaged in the business of manufacturing specialty chemicals offering water treatment solutions to global customers across diverse end markets

PCBL to acquire Aquapharm Chemicals for Rs3,800 crore

The Board of Directors of PCBL Limited has approved the acquisition of 2,12,172 shares of Aquapharm Chemicals Private Limited (ACPL), for an aggregate consideration of Rs 3,800 crores representing 100 per cent of the issued and paid-up share capital (on a fully diluted basis) of ACPL.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.